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Purpose of the study
Significantly higher plasma exposure of some protease inhibitors (PIs) has been observed in Thai subjects compared to Caucasians. These differences may partially be explained by factors such as body weight and diet. However, pharmacogenetic differences may also contribute. The aim of this study was to investigate, in a Thai population, the frequency of functional polymorphisms in genes known to influence plasma concentrations of antiretroviral drugs.
Methods
Eighty-four Thai subjects were included in this study. Genotyping for CYP2B6 (516G>T and 983T>C), CYP3A4 (-392A>G), CYP3A5 (6986A>G), ABCB1 (1236C>T, 3435C>T and 2677G>T), ABCC1 (-260G>C), ABCG2 (421C>A), SLCO1B1 (521T>C) and PXR (63396C>T and 44477T>C) was conducted by real-time PCR based allelic discrimination. Hardy-Weinberg equilibrium was assessed by χ 2 test of observed versus predicted genotype frequencies. Fisher's exact test was used to determine differences in allele frequency between Thai and previously reported Caucasian populations.
Summary of results
All genotype frequencies were in the Hardy-Weinberg equilibrium. The minor allele frequency for 516G>T, 983T>C, -392A>G, 3435C>T, 2677G>T, -260G>C and 521T>C was 0. 
Conclusion
Although the different allele frequencies for ABCB1 and ABCG2 could have a modest impact on the bioavailability, the over-representation of CYP3A5 6986 G would be expected to result in lower drug concentrations of PIs. However, we have previously shown an association of PXR SNPs with atazanavir plasma concentrations and so genotype-phenotype studies for these SNPs in Thai populations are now warranted.
from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9-13 November 2008
